Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Annual Financial Report

19 Dec 2017 15:26

RNS Number : 8351Z
McCarthy & Stone PLC
19 December 2017
 

19 December 2017

 

McCarthy & Stone plc (the Company)

Annual Report and Accounts and Notice of Annual General Meeting

 

Further to the Company's announcement on 14 November 2017 of its annual financial results to 31 August 2017, the Annual Report has today been sent to shareholders together with the Notice of the 2018 Annual General Meeting, which will be held at the offices of Addleshaw Goddard LLP, Milton Gate, 60 Chiswell Street, London EC1Y 4AG at 10.00am on Wednesday 24 January 2018.

In accordance with Listing Rule 9.6.1R copies of the Annual Report, the Notice of Annual General Meeting of the Company and the Form of Proxy have been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM.

The Annual Report and the Notice of Meeting will also be available to download from the Company's website at www.mccarthyandstonegroup.co.uk and hard copies can be requested from the registered office, Fourth Floor, 100 Holdenhurst Road, Bournemouth, Dorset BH8 8AQ.

For further information please contact:

Patrick Hole

Group General Counsel and Company Secretary

Telephone: 01202 508040

 

The appendix to this announcement (Appendix) is a supplement to Company's announcement on 14 November 2017 of its annual financial results to 31 August 2017 (the Results Announcement). It contains the information required to be communicated in unedited full text pursuant to DTR 6.3.5 that is in addition to the information communicated in the Results Announcement. The Appendix should be read together with the Results Announcement.

 

 

 

Appendix

The Directors confirm that, to the best of each person's knowledge:

· The financial statements, prepared in accordance with International Financial Reporting Standards as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation taken as a whole

· The Strategic Report includes a fair review of the development and performance of the business and the position of the Company and the undertakings included in the consolidation taken as a whole, together with a description of the principal risks and uncertainties that they face

 

This responsibility statement was approved by the Board of Directors on 13 November 2017 and is signed on its behalf by:

 

 

Clive Fenton Rowan Baker

Chief Executive Officer Chief Financial Officer

13 November 2017 13 November 2017

 

 

- Ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSFFLFIUFWSEEE
Date   Source Headline
31st Jul 20208:23 amRNSDirectorate Change
29th Jul 20205:41 pmRNSHolding(s) in Company
15th Jul 20207:01 amRNSDirectorate Change
15th Jul 20207:00 amRNSHalf Year Results
3rd Jul 20209:00 amRNSNotice of Interim Results
22nd Jun 20204:11 pmRNSHolding(s) in Company
9th Jun 20204:18 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSCOVID-19 Business Update
1st Jun 20209:30 amRNSDirector/PDMR Shareholding
28th May 202012:13 pmRNSDirector/PDMR Shareholding
19th May 20201:11 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirectorate Change
1st May 20207:00 amRNSTotal Voting Rights
1st May 20207:00 amRNSHolding(s) in Company
30th Apr 20205:56 pmRNSSale of assets to Waverstone LLP
29th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
7th Apr 202011:41 amRNSAdditional Listing
2nd Apr 20204:28 pmRNSDirector/PDMR Shareholding
27th Mar 20202:37 pmRNSHolding(s) in Company
25th Mar 202011:14 amRNSResults of Annual General Meeting
25th Mar 20207:00 amRNSAGM & Business Update
24th Mar 20201:37 pmRNSHolding(s) in Company
20th Mar 20204:17 pmRNSAnnual General Meeting and Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 202010:56 amRNSCOVID-19 update
12th Mar 202011:44 amRNSHolding(s) in Company
2nd Mar 20209:14 amRNSTotal Voting Rights
19th Feb 202010:03 amRNSAnnual Financial Report
11th Feb 202010:22 amRNSDirector/PDMR Shareholding
7th Feb 20208:32 amRNSDirector/PDMR Shareholding
3rd Feb 20201:50 pmRNSHolding(s) in Company
3rd Feb 20209:16 amRNSBlock listing Interim Review
3rd Feb 20209:04 amRNSTotal Voting Rights
29th Jan 20203:45 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSFull Year Results
15th Jan 202010:40 amRNSDirector Declaration
13th Jan 20207:00 amRNSNotice of Results
10th Jan 20207:00 amRNSAppointment - General Counsel & Company Secretary
9th Jan 20202:35 pmRNSHolding(s) in Company
2nd Jan 202010:30 amRNSTotal Voting Rights
12th Dec 20199:12 amRNSDirectorate Change
15th Nov 20198:55 amRNSDirector/PDMR Shareholding
14th Nov 20198:06 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSHolding(s) in Company
7th Nov 20199:09 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSFY19 Trading Update
1st Nov 20198:27 amRNSDirectorate Change
24th Oct 20198:05 amRNSHolding(s) in Company
22nd Oct 20193:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.